TY - JOUR
T1 - Bone cell mitogenic action of fluoroaluminate and aluminum fluoride but not that of sodium fluoride involves upregulation of the insulin-like growth factor system
AU - Lau, K. H.
AU - Goodwin, C.
AU - Arias, M.
AU - Mohan, S.
AU - Baylink, D. J.
N1 - Funding Information:
This work was supported in part by a research grant from the National Institutes of Health (1 RO1 DE08681, to K.-H.W.L. and 1 RO1 AR31062 to S.M.), and by a VA merit review grant (to D.J.B.) from the Office of Research and Development, Department of Veterans Affairs. All work was performed in facilities provided by the Department of Veterans Affairs.
PY - 2002
Y1 - 2002
N2 - The fluoroaluminate (AlF4-) ion and sodium fluoride (NaF) have previously been shown to be bone cell mitogens. This study sought to determine whether the bone cell mitogenic action of AlF4- and/or NaF would involve the insulin-like growth factor (IGF) regulatory system. We evaluated the effect of mitogenic doses of AlF4- and NaF on the mRNA levels and the protein level (in conditioned media [CM]) of several components of the IGF system (i.e., IGF-2, IGF binding protein [IGFBP]-4, and IGFBP-5) in human TE85 osteosarcoma cells. Aluminum fluoride (AlF3) was included for comparison. NaF, AlF3, and AlF4-, each at 50-100 μmol/L, increased [3H]thymidine incorporation in TE85 cells. Mitogenic concentrations of AlF3 and AlF4-: (1) increased the mRNA (up to twofold after 24 h treatment) and protein (in CM) levels (up to 2.5-fold after 48 h treatment) of IGF-2; (2) increased the mRNA level (twofold) and the protein level in CM (up to threefold) of stimulatory IGFBP-5; and (3) either reduced slightly or had no effect on the mRNA and protein (in CM) levels of the inhibitory IGFBP-4. Conversely, mitogenic concentrations of NaF had no significant effects on the protein (in CM) or mRNA level of IGF-2, IGFBP-4, or IGFBP-5. The addition of an inhibitory concentration of IGFBP-4 completely abolished the bone cell mitogenic activity of AlF3 and AlF4- but not that of NaF. The findings of this study provide strong evidence that the bone cell mitogenic activity of AlF4- and AlF3, but not that of NaF, is mediated by the upregulation of the IGF regulatory system.
AB - The fluoroaluminate (AlF4-) ion and sodium fluoride (NaF) have previously been shown to be bone cell mitogens. This study sought to determine whether the bone cell mitogenic action of AlF4- and/or NaF would involve the insulin-like growth factor (IGF) regulatory system. We evaluated the effect of mitogenic doses of AlF4- and NaF on the mRNA levels and the protein level (in conditioned media [CM]) of several components of the IGF system (i.e., IGF-2, IGF binding protein [IGFBP]-4, and IGFBP-5) in human TE85 osteosarcoma cells. Aluminum fluoride (AlF3) was included for comparison. NaF, AlF3, and AlF4-, each at 50-100 μmol/L, increased [3H]thymidine incorporation in TE85 cells. Mitogenic concentrations of AlF3 and AlF4-: (1) increased the mRNA (up to twofold after 24 h treatment) and protein (in CM) levels (up to 2.5-fold after 48 h treatment) of IGF-2; (2) increased the mRNA level (twofold) and the protein level in CM (up to threefold) of stimulatory IGFBP-5; and (3) either reduced slightly or had no effect on the mRNA and protein (in CM) levels of the inhibitory IGFBP-4. Conversely, mitogenic concentrations of NaF had no significant effects on the protein (in CM) or mRNA level of IGF-2, IGFBP-4, or IGFBP-5. The addition of an inhibitory concentration of IGFBP-4 completely abolished the bone cell mitogenic activity of AlF3 and AlF4- but not that of NaF. The findings of this study provide strong evidence that the bone cell mitogenic activity of AlF4- and AlF3, but not that of NaF, is mediated by the upregulation of the IGF regulatory system.
KW - Aluminum fluoride
KW - Bone cells (human)
KW - Fluoroaluminate
KW - Insulin-like growth factor
KW - Proliferation
KW - Sodium fluoride
UR - http://www.scopus.com/inward/record.url?scp=0036252124&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036252124&partnerID=8YFLogxK
U2 - 10.1016/S8756-3282(02)00671-3
DO - 10.1016/S8756-3282(02)00671-3
M3 - Article
C2 - 11996908
SN - 8756-3282
VL - 30
SP - 705
EP - 711
JO - Bone
JF - Bone
IS - 5
ER -